2012
DOI: 10.1016/s0020-7292(12)60028-9
|View full text |Cite
|
Sign up to set email alerts
|

Principles of chemotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…Chemotherapeutic drugs, such as the anti-metabolite 5-Fluorouracil (5-FU) are broadly effective at treating solid tumours and haematological malignancies 1 . However, these cytotoxic agents indiscriminately target both malignant and normal dividing cells of the gastrointestinal tract; often resulting in the serious condition known as mucositis 2 . Mucositis is characterised by ulceration and inflammation of the mucosa with clinical symptoms including severe pain, rectal bleeding, bloating, nausea, vomiting and diarrhoea 3,4 .…”
Section: Introductionmentioning
confidence: 99%
“…Chemotherapeutic drugs, such as the anti-metabolite 5-Fluorouracil (5-FU) are broadly effective at treating solid tumours and haematological malignancies 1 . However, these cytotoxic agents indiscriminately target both malignant and normal dividing cells of the gastrointestinal tract; often resulting in the serious condition known as mucositis 2 . Mucositis is characterised by ulceration and inflammation of the mucosa with clinical symptoms including severe pain, rectal bleeding, bloating, nausea, vomiting and diarrhoea 3,4 .…”
Section: Introductionmentioning
confidence: 99%
“…Neutropenia usually occurs 7–10 days after chemotherapy. It can increase the risk of a complication of infection and fever known as febrile neutropenia (FN) [ 6 ]. In several papers, they consider the prediction of the occurrence of neutropenia in breast cancer patients [ [7] , [8] , [9] ].…”
Section: Introductionmentioning
confidence: 99%
“…Neutropenia usually occurs 7 to 10 days after chemotherapy. It can increase the risk of a complication of infection and fever known as febrile neutropenia (FN) [11]. In several papers, they consider the prediction of the occurrence of neutropenia in breast cancer patients.…”
Section: Introductionmentioning
confidence: 99%